Abstract
The Semmelweis Study is a prospective occupational cohort study that seeks to enroll all employees of Semmelweis University (Budapest, Hungary) aged 25 years and older, with a population of 8866 people, 70.5% of whom are women. The study builds on the successful experiences of the Whitehall II study and aims to investigate the complex relationships between lifestyle, environmental, and occupational risk factors, and the development and progression of chronic age-associated diseases. An important goal of the Semmelweis Study is to identify groups of people who are aging unsuccessfully and therefore have an increased risk of developing age-associated diseases. To achieve this, the study takes a multidisciplinary approach, collecting economic, social, psychological, cognitive, health, and biological data. The Semmelweis Study comprises a baseline data collection with open healthcare data linkage, followed by repeated data collection waves every 5 years. Data are collected through computer-assisted self-completed questionnaires, followed by a physical health examination, physiological measurements, and the assessment of biomarkers. This article provides a comprehensive overview of the Semmelweis Study, including its origin, context, objectives, design, relevance, and expected contributions.
| Original language | English |
|---|---|
| Pages (from-to) | 191-218 |
| Number of pages | 28 |
| Journal | GeroScience |
| Volume | 46 |
| Issue number | 1 |
| Early online date | 7 Dec 2023 |
| DOIs | |
| Publication status | Published - Feb 2024 |
Bibliographical note
Publisher Copyright:© 2023, The Author(s).
Funding
Funding for the initial infrastructure and the baseline data collection of the study has been provided by a series of grants obtained from the Ministry of Innovation and Technology of Hungary, the National Research, Development and Innovation Fund, the European University for Well-Being (EUniWell) program, and by the leadership of Semmelweis University through the allocation of resources for the purposes of the study. Once the cohort is assembled, continuing support will be sought from Semmelweis University and national and international funding organizations. The leadership team of the Semmelweis Study will apply for research funding from a variety of sponsors, including the National Research, Development and Innovation Fund, the Hungarian Academy of Sciences, the European Research Council, and private foundations. The goal is to secure funding to allow for an increasingly rich data collection in the upcoming phases through personal contact with the cohort participants. Open access funding provided by Semmelweis University. Project no. TKP2021-NKTA-47 has been implemented with the support provided by the Ministry of Innovation and Technology of Hungary from the National Research, Development and Innovation Fund, financed under the TKP2021-NKTA funding scheme. Funding for the project through the National Cardiovascular Laboratory Program (RRF-2.3.1–21-2022–00003) was provided by the Ministry of Innovation and Technology of Hungary from the National Research, Development and Innovation Fund. Project no. 135784 has also been implemented with the support provided from the National Research, Development and Innovation Fund of Hungary, financed under the K_20 funding scheme. This work was also supported by grants from the National Research, Development and Innovation Office (RRF-2.3.1-NKL), the Hungarian Academy of Sciences (TK2016-78) and the European University for Well-Being (EUniWell) program (grant agreement number: 101004093/ EUniWell/EAC-A02-2019 / EAC-A02-2019–1). The project has received funding from the HUN-REN Hungarian Research Network (TKCS-2021/32). Dr Adam Tabák was supported by the UK Medical Research Council (S011676), NordForsk (the Nordic Research Programme on Health and Welfare, 75021). Dr. Daniel W. Belsky is a fellow of the CIFAR CBD Network. Dr Mika Kivimäki is supported by the Wellcome Trust (221854/Z/20/Z), the Medical Research Council (R024227, S011676), the National Institute on Aging (R01AG056477, R01AG062553), and Academy of Finland (350426). Drs. Anna Csiszar, Zoltan Ungvari, Peter Mukli and Andriy Yabluchanskiy were supported by the National Institute on Aging (RF1AG072295, R01AG055395, R01AG068295; R01AG070915, R03AG070479), the National Institute of Neurological Disorders and Stroke (R01NS100782), the National Cancer Institute (R01CA255840), the Oklahoma Shared Clinical and Translational Resources (U54GM104938) with an Institutional Development Award (IDeA) from NIGMS, the Presbyterian Health Foundation, the Reynolds Foundation, the Oklahoma Nathan Shock Center (P30AG050911), and the Cellular and Molecular GeroScience CoBRE (P20GM125528). The funding sources had no role in the study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.
| Funders | Funder number |
|---|---|
| Presbyterian Health Foundation | |
| National Institute of General Medical Sciences | |
| Ministry of Innovation and Technology | |
| Semmelweis Egyetem | |
| Ministry of Innovation and Technology of Hungary | |
| European Research Council | |
| Richard S. Reynolds Foundation | |
| Wellcome Trust | 221854/Z/20/Z, 221854 |
| Nemzeti Kutatási Fejlesztési és Innovációs Hivatal | RRF-2.3.1-NKL |
| National Institute of Neurological Disorders and Stroke | R01NS100782 |
| NordForsk | 75021 |
| Medical Research Council | MR/S011676/1, R024227, S011676 |
| National Cancer Institute | R01CA255840 |
| Academy of Finland | R01AG070915, R01AG068295, R01AG055395, RF1AG072295, R03AG070479 |
| Oklahoma Shared Clinical and Translational Resources | U54GM104938 |
| National Cardiovascular Laboratory Program | RRF-2.3.1–21-2022–00003, 135784 |
| European University for Well-Being | 101004093/ EUniWell/EAC-A02-2019 / EAC-A02-2019–1 |
| National Health and Medical Research Council | 350426 |
| HUN-REN Hungarian Research Network | TKCS-2021/32 |
| Magyar Tudományos Akadémia | TK2016-78 |
| Oklahoma Nathan Shock Center | P30AG050911 |
| National Institute on Aging | R01AG062553, R01AG056477 |
| Nemzeti Kutatási, Fejlesztési és Innovaciós Alap | TKP2021-NKTA-47 |
| Cellular and Molecular GeroScience CoBRE | P20GM125528 |
Keywords
- Age-associated diseases
- Biological age
- Central Europe
- Epidemiology
- Health Promoting University
- Healthy aging
- Workplace cohort